JDD November Issue
Here are the highlights for the November issue of JDD, which has a special focus on lasers, light sources, and devices.
Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes reviews of the application of microfocused ultrasound in combination with injectable dermal fillers as a treatment approach for lifting skin on the neck and …
Here are the highlights for the November issue of JDD, which has a special focus on lasers, light sources, and devices.
Facial Skin Tightening With Microfocused Ultrasound and Dermal Fillers: Considerations for Patient Selection and Outcomes reviews of the application of microfocused ultrasound in combination with injectable dermal fillers as a treatment approach for lifting skin on the neck and … 
Here are the issue highlights for the October issue of JDD!
Characterizing how AD patients are currently treated may build a reference for future clinical research in Prescribing Patterns for Atopic Dermatitis in the United States.
A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old explores early intervention in infants and you … 
Authors Ross Tanis MD MS, Katalin Ferenczi MD, and B Michael Payette MD MBAB present a case where they demonstrated that treatment of Prurigo Nodularis (PN) with dupilumab significantly decreased pruritis and the size and number of new lesions after 2 months of treatment.
INTRODUCTION
Prurigo nodularis is an intensely pruritic skin disease in which dome-shaped papulonodules result from chroni … 
Here are the highlights from the September issue of JDD!
For African American women, concerns about facial aging may be more about pigmentary concerns and shifts in underlying soft tissue volume in Understanding the Female African American Facial Aesthetic Patient.
Authors evaluate long-term safety and efficacy of ATX-101 for submental fat reduction in ATX-101 (Deoxycholic Ac … 
Abstract
Botulinum toxin type A (BTA) is a neurotoxic protein that prevents the release of neurotransmitters from presynaptic nerves and has shown promise in treating neuropathic pain. Recently, BTA has been used to treat painful keloids and scars. We present a patient with refractory neuropathic pain in a normotrophic spread-scar treated with the injection of BTA.
A 47-year-old Caucasian female …